Dr. Michael Salgaller currently works at the National Cancer Institute*, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. Previously, he provided technical and strategic expertise to The Conafay Group, a DC-based government affairs firm – leading efforts on non-dilutive funding and alliance development. Prior to that, he was a key member of the business development team for the healthcare practice at SAIC, a Fortune-500 government contractor. He helped lead and deepen relationships with the Department of Health and Human Services – especially NIH and FDA – as well as foundations and patient advocacy groups. Before SAIC, he was a long-time industry executive who has held various positions in biotechnology and professional service firms including interim President of Biologics Consulting Firm, a boutique regulatory affairs consulting firm. In addition, Dr. Salgaller was on the investment team of Toucan Capital, a $120M early-stage venture firm dedicated to the life sciences, where he guided company formation and helped raise over $40M in follow-on financing. He began his career as a Senior Staff Scientist at the National Cancer Institute, where he oversaw a lab developing treatments for patients with terminal illnesses.

Dr. Salgaller serves on the Life Sciences Advisory Board of the Maryland Technology Council, and as a liaison to the Maryland-Israel Development Corporation and Maryland Technology Council. He is a reviewer for Washington DC ArchAngels and the Cooperative Angel Alumni Group. He is the author of “Biotechnology Entrepreneurship,” which is used as a reference text for courses at NIH and Catholic University, among others. He is an author of over 100 articles, presentations, and book chapters, and is on the editorial boards of several journals. For several years, he has served on the selection committee for Maryland’s Incubator Company of the Year Awards. Dr. Salgaller received his PhD in Pathology from The Ohio State University.


* Dr. Salgaller is serving in his personal capacity.

Michael Salgaller